| "RAINBOW extension study: an extension study to evaluate the long term efficacy and safety of RAnibizumab compared with laser therapy for the treatment of Infants BOrn prematurely With retinopathy of prematurity" |
Completed |
Ranibizumab |
3 |
CRFB002H2301E1 |
KFSH & RC-R |
| Real-World Experience of Upadacitinib in Moderate to Severe Atopic Dermatitis |
Ongoing |
Upadacitinib (Rinvoq) |
4 |
H23-107 |
King Faisal General Hospital (Makkah), Mohammed Dossary Hospital - Al Khobar, King Fahad Central Hospital (Jazan), East Jeddah General Hospital, Hira Hospital (Makkah) , Aseer Central Hospital (Abha) |
| An Open-Label Study in Adolescent and Adult Severe (Coagulation Factor Activity <1%) Hemophilia A or B Patients With or Without Inhibitors Comparing Standard Treatment to PF-06741086 Prophylaxis |
Ongoing |
PF-06741086 |
3 |
B7841005 |
King Abdulaziz University Hospital (Jeddah) |
| Acute Effect of seaweed (Ecklonia cava extract) on blood glucose and insulin level in pre-diabetic patients: A double-blind randomized-controlled trial |
Ongoing |
Ecklonia cava extract |
3 |
SW2020 |
King Khalid University Hospital (Riyadh) |
| A Phase III, Multicenter, Randomized, parallel-group study to asses the efficacy and saftey of double-blind pasireotide LAR 40 mg and pasireotide LAR 60 mg versus open lable octreotide LAR or lanreotide ATG in patients with inadequately controlled acromegaly. |
Ongoing |
Pasireotide |
3 |
CSOM230C2402 |
NGHA-R |
| A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY, SAFETY, TOLERABILITY AND PHARMACOKINETICS OF PF-06687234 AS ADD-ON THERAPY TO INFLIXIMAB IN ACTIVE ULCERATIVE COLITIS SUBJECTS WHO ARE NOT IN REMISSION (BUILD UC) |
Completed |
PF-06687234 |
2a |
B7581002 |
NGHA-R |
| "A PHASE 2/3, MULTICENTER, MULTINATIONAL, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALXN1101 IN NEONATES WITH MOLYBDENUM COFACTOR DEFICIENCY (MOCD) TYPE A" |
Terminated |
ALXN1101( Cyclic pyranopterin monophosphate monohydrobromide dihydrate) |
2/3 |
ALXN1101-MCD-202 |
KFMC |
| A 12-week, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of QAW039 when added to standard-of-care asthma therapy in patients with uncontrolled asthma |
Completed |
QAW039/Fevipiprant |
3 |
CQAW039A2316 |
KFMC |
| Use of high dose of Colistin in Multidrug Resistant Gram Negative infections. Randomized Controlled clinical Trial |
Completed |
Colistin |
4 |
KSMC-12-13 |
King Saud Medical City |
| "easypod connect: A regional, Multicentre, Observational study to evaluate Adherenceand Long Term Outcomes of Therapy in Paediatric subjects using “easypodTM” electromechanical device for growth hormone treatment" |
Rejected |
- |
4 |
200104-534 |
King Khalid University Hospital (Riyadh) |
